Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes

HPB

Volumn 14, Issue 8, 2012, Pages 539-547

  Visser, Brendan C ^a   Ma, Yifei ^a   Zak, Yulia ^a   Poultsides, George A ^a   Norton, Jeffrey A ^a   Rhoads, Kim F ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Compliance; Guidelines; NCCN; Outcomes; Pancreatic neoplasia

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMORBIDITY; DEMOGRAPHY; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREAS RESECTION; PRACTICE GUIDELINE; SOCIAL STATUS; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

EID: 84863727880     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00496.x     Document Type: Article

References (45)

1. American College of Surgeons website. (2012) [accessed March 2012].
2. Donabedian A,. (1980) Explorations in Quality Assessment and Monitoring: The Definition of Quality and Approaches to Its Assessment. Vol. 1. Ann Arbor, MI: Health Administration Press.
3. Hawn MT, Vick CC, Richman J, Holman W, Deierhoi RJ, Graham LA, et al,. (2011) Surgical site infection prevention: time to move beyond the surgical care improvement program. Ann Surg 254: 494-499; discussion 499-501.
4. Birkmeyer JD, Dimick JB, Birkmeyer NJ,. (2004) Measuring the quality of surgical care: structure, process, or outcomes? J Am Coll Surg 198: 626-632.
5. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL., (2006) Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol 24: 626-634.
6. Birkmeyer JD, Sun Y, Wong SL, Stukel TA,. (2007) Hospital volume and late survival after cancer surgery. Ann Surg 245: 777-783.
7. Glasgow RE, Mulvihill SJ,. (1996) Hospital volume influences outcome in patients undergoing pancreatic resection for cancer. West J Med 165: 294-300.
8. Sosa JA, Bowman HM, Gordon TA, Bass EB, Yeo CJ, Lillemoe KD, et al,. (1998) Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 228: 429-438.
9. Gasper WJ, Glidden DV, Jin C, Way LW, Patti MG., (2009) Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference?: A follow-up analysis of another decade. Ann Surg 250: 472-483.
10. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al,. (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 63: 1308-1311.
11. Browman GP, Brouwers M,. (2009) The role of guidelines in quality improvement for cancer surgery. J Surg Oncol 99: 467-469.
12. Bahtsevani C, Uden G, Willman A,. (2004) Outcomes of evidence-based clinical practice guidelines: a systematic review. Int J Technol Assess Health Care 20: 427-433.
13. Erickson Foster J, Velasco JM, Hieken TJ,. (2008) Adverse outcomes associated with noncompliance with melanoma treatment guidelines. Ann Surg Oncol 15: 2395-2402.
14. Lewis CM, Hessel AC, Roberts DB, Guo YZ, Holsinger FC, Ginsberg LE, et al,. (2010) Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines. Arch Otolaryngol Head Neck Surg 136: 1205-1211.
15. O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, et al,. (2011) Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative. Clin Colorectal Cancer 10: 113-116.
16. California Cancer Registry, California Dept. of Health Services., Public Health Institute (Calif.), California Association of Regional Cancer Registries. (2003) Research Utilizing the California Cancer Registry. Sacramento, CA: California Dept. of Health Services, Cancer Surveillance Section.
17. California Hospital Annual Financial Datafile [HAFD]. (2012) Accessed 3/2012.
18. Olaya W, Wong JH, Morgan JW, Roy-Chowdhury S, Lum SS., (2009) Disparities in the surgical management of women with stage I breast cancer. Am Surg 75: 869-872.
19. Wong R, Corley DA,. (2008) Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med 121: 525-531.
20. NCCN. (2000) NCCN Practice Guidelines for Pancreatic Cancer 2000. (obtained on request from NCCN).
21. Fleming ID, American Joint Committee on Cancer, American Cancer Society, American College of Surgeons. (1997) AJCC Cancer Staging Manual, 5th edn. Philadelphia, PA: Lippincott-Raven.
22. Evans DB, Farnell MB, Lillemoe KD, Vollmer C, Jr., Strasberg SM, Schulick RD., (2009) Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16: 1736-1744.
23. Burris HA, 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al,. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413.
24. Kalser MH, Ellenberg SS,. (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899-903.
25. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al,. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297: 267-277.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
27. Deyo RA, Cherkin DC, Ciol MA,. (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619.
28. Bilimoria KY, Bentrem DJ, Ko CY, Tomlinson JS, Stewart AK, Winchester DP, et al,. (2007) Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume. Cancer 110: 1227-1234.
29. Bilimoria KY, Talamonti MS, Wayne JD, Tomlinson JS, Stewart AK, Winchester DP, et al,. (2008) Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg 143: 671-678.
30. Spencer BA, Miller DC, Litwin MS, Ritchey JD, Stewart AK, Dunn RL, et al,. (2008) Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol 26: 3735-3742.
31. Zak Y, Rhoads KF, Visser BC,. (2011) Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type. Arch Surg 146: 778-784.
32. Rhoads KF, Cullen J, Ngo JV, Wren SM,. (2012) Racial and ethnic differences in lymph node examination after colon cancer resection do not completely explain disparities in mortality. Cancer 118: 469-477.
33. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al,. (1999) Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282: 1458-1465.
34. Ramsey SD, Cheadle AD, Neighbor WE, Gore E, Temple P, Staiger T, et al,. (2001) Relative impact of patient and clinic factors on adherence to primary care preventive service guidelines: an exploratory study. Med Care 39: 979-989.
35. Ghali JK, Massie BM, Mann DL, Rich MW,. (2010) Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Am Coll Cardiol 56: 2077-2080.
36. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS., (2007) National failure to operate on early stage pancreatic cancer. Ann Surg 246: 173-180.
37. Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, et al,. (2011) Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol 18: 2126-2135.
38. Gupta PK, Turaga KK, Miller WJ, Loggie BW, Foster JM,. (2011) Determinants of outcomes in pancreatic surgery and use of hospital resources. J Surg Oncol 104: 634-640.
39. Robinson DW, Jr, Eisenberg DF, Cella D, Zhao N, de Boer C, DeWitte M., (2008) The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. J Support Oncol 6: 283-290.
40. Walter LC, Davidowitz NP, Heineken PA, Covinsky KE,. (2004) Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA 291: 2466-2470.
41. Bilimoria KY, Bentrem DJ, Lillemoe KD, Talamonti MS, Ko CY., (2009) Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst 101: 848-859.
42. National Quality Forum. (2012) [accessed March 2012].
43. Agency for Health Care Research and Policy (AHRQ). (2012) [accessed March 2012].
44. Bentrem DJ, Brennan MF,. (2005) Outcomes in oncologic surgery: does volume make a difference? World J Surg 29: 1210-1216.
45. Kamphues C, Bova R, Schricke D, Hippler-Benscheidt M, Klauschen F, Stenzinger A, et al,. (2012) Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. Ann Surg Oncol 19: 856-863.